Ms. Ma Zhitao | Herbal Medicine | Best Researcher Award
Associate Research Scientist at Beijing Children’s Hospital, Capital medical university, China.
Ms. Ma Zhitao is an accomplished researcher in microbiology and hepatology, currently serving as an Associate Research Scientist at Beijing Children’s Hospital, Capital Medical University. With over a decade of expertise in traditional Chinese medicine (TCM), liver pathophysiology, and drug-induced liver injury, she combines cutting-edge metabolomic techniques and animal models to explore novel interventions for alcoholic liver disease (ALD) and herb-induced liver toxicity. She has authored over 20 peer-reviewed publications in high-impact journals and holds two national patents, showcasing her contributions to both academic science and translational research.
Professional Profile ,
Education 🎓📚
-
PhD in Microbiology – China Agricultural University, 2008.09 – 2014.01
-
Bachelor’s in Biology – Shanxi University, 2004.09 – 2008.07
Professional Experience 🧑🏫💼
-
Associate Research Scientist
Beijing Children’s Hospital, Capital Medical University
2025.06 – Present-
Research focus: Pediatric hepatology, metabolomic markers in ALD, and clinical translation.
-
-
Researcher
College of Traditional Chinese Medicine, Capital Medical University
2021.04 – 2025.05-
Investigated ALD mechanisms and treatment using clinical herbal formulations.
-
Focus on herb-induced liver injury and metabolomics-based evaluations.
-
-
Assistant Researcher
College of Life Science, Beijing University of Chinese Medicine
2014.07 – 2020.12-
Developed preclinical drug evaluation platforms.
-
Studied hepatotoxicity and therapeutic potentials of TCM components in cancer and liver disease models.
-
Research Interest 🔬📈
-
Alcoholic Liver Disease (ALD) Pathogenesis
-
Herb-induced Liver Injury (HILI)
-
Metabolomics in Hepatology
-
Traditional Chinese Herbal Medicine
-
Drug-Induced Liver Fibrosis & Autoimmune Reactions
-
NAD⁺ and Liver Energy Metabolism
🧪 Selected Publications
-
Restoring energy metabolism by NAD⁺ supplement prevents alcohol-induced liver injury (2024, Food Sci & Nutr).
-
A clinical herbal formula improves steatohepatitis in mice (Chinese Medicine, 2023).
-
New insights into herb-induced liver injury (Antioxid Redox Signal, 2023).
-
Metabolomics reveals lipid/amino acid disturbances in ALD progression (Front Med, 2022).
-
Profiling liver autoantibodies in drug-induced liver injury (Int Immunopharmacol, 2022).
-
Bioluminescent oxidative stress imaging and fertility studies (Free Radic Biol Med, 2018).
Article Summary
Title: Tetramethylpyrazine: A fermented alcohol product that mitigates alcoholic liver disease in mice
Journal: Free Radical Biology and Medicine, 2025
Conclusion 🌟🎯
Ms. Ma Zhitao demonstrates exceptional caliber, innovation, and scientific rigor in her research at the intersection of herbal medicine, hepatology, and metabolomics. Her unique integration of traditional Chinese medicine with modern biomedical tools sets her apart as a leader in translational research for liver disease treatment.